IDEXX LABORATORIES INC /DE Inventory, Finished Goods, Net of Reserves
IDEXX LABORATORIES INC /DE (IDXX) had Inventory, Finished Goods, Net of Reserves of $251.46 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Inventory, Net, Items Net of Reserve Alternative › Inventory, Finished Goods and Work in Process, Net of Reserves
us-gaap:InventoryFinishedGoodsNetOfReserves · last filed 2026-08-04
- 2026-06-30: Inventory, Finished Goods, Net of Reserves $251.46M.
- 2026-03-31: Inventory, Finished Goods, Net of Reserves $249.86M.
- 2025-12-31: Inventory, Finished Goods, Net of Reserves $248.87M.
- 2025-09-30: Inventory, Finished Goods, Net of Reserves $255.09M.
| Period end | Inventory, Finished Goods, Net of Reserves |
|---|---|
| 2026-06-30 | $251.46M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $249.86M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $248.87M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $255.09M 10-Q · filed 2025-11-03 |
| 2025-06-30 | $253.41M 10-Q · filed 2025-08-04 |
| 2025-03-31 | $256.27M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $245.78M 10-K · filed 2026-02-20 |
| 2024-09-30 | $250.56M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $243.83M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $259.32M 10-Q · filed 2024-05-01 |
| 2023-12-31 | $244.90M 10-K · filed 2025-02-21 |
| 2023-09-30 | $254.55M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $258.30M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $257.27M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $246.99M 10-K · filed 2024-02-22 |
| 2022-09-30 | $238.47M 10-Q · filed 2022-11-01 |
| 2022-06-30 | $216.53M 10-Q · filed 2022-08-02 |
| 2022-03-31 | $200.74M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $182.21M 10-K · filed 2023-02-16 |
| 2021-09-30 | $174.26M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $157.17M 10-Q · filed 2021-07-30 |
| 2021-03-31 | $146.47M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $143.51M 10-K · filed 2022-02-16 |
| 2020-09-30 | $151.22M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $159.93M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $148.38M 10-Q · filed 2020-04-30 |
| 2019-12-31 | $133.74M 10-K · filed 2021-02-12 |
| 2019-09-30 | $144.43M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $139.47M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $136.52M 10-Q · filed 2019-05-01 |
| 2018-12-31 | $124.32M 10-K · filed 2020-02-14 |
| 2018-09-30 | $128.92M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $125.17M 10-Q · filed 2018-08-01 |
| 2018-03-31 | $125.83M 10-Q · filed 2018-05-04 |
| 2017-12-31 | $113.54M 10-K · filed 2019-02-15 |
| 2017-09-30 | $126.30M 10-Q · filed 2017-10-31 |
| 2017-06-30 | $122.03M 10-Q · filed 2017-08-01 |
| 2017-03-31 | $125.15M 10-Q · filed 2017-04-28 |
| 2016-12-31 | $115.47M 10-K · filed 2018-02-16 |
| 2016-09-30 | $122.04M 10-Q · filed 2016-11-01 |
| 2016-06-30 | $128.26M 10-Q · filed 2016-08-02 |
| 2016-03-31 | $132.29M 10-Q · filed 2016-04-29 |
| 2015-12-31 | $138.95M 10-K · filed 2017-02-17 |
| 2015-09-30 | $141.15M 10-Q · filed 2015-10-28 |
| 2015-06-30 | $133.78M 10-Q · filed 2015-07-30 |
| 2015-03-31 | $126.24M 10-Q · filed 2015-04-28 |
| 2014-12-31 | $116.58M 10-K · filed 2016-02-17 |
| 2014-09-30 | $113.44M 10-Q · filed 2014-10-24 |
| 2014-06-30 | $105.60M 10-Q · filed 2014-07-25 |
| 2014-03-31 | $101.52M 10-Q · filed 2014-04-25 |
| 2013-12-31 | $95.30M 10-K · filed 2015-02-17 |
| 2013-09-30 | $105.57M 10-Q · filed 2013-10-22 |
| 2013-06-30 | $100.94M 10-Q · filed 2013-07-23 |
| 2013-03-31 | $106.34M 10-Q · filed 2013-04-23 |
| 2012-12-31 | $97.93M 10-K · filed 2014-02-18 |
| 2012-09-30 | $99.75M 10-Q · filed 2012-10-19 |
| 2012-06-30 | $97.92M 10-Q · filed 2012-07-20 |
| 2012-03-31 | $92.79M 10-Q · filed 2012-04-20 |
| 2011-12-31 | $89.87M 10-K · filed 2013-02-19 |
| 2011-09-30 | $94.14M 10-Q · filed 2011-10-21 |
| 2011-06-30 | $89.66M 10-Q · filed 2011-07-22 |
| 2010-12-31 | $87.34M 10-K · filed 2012-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |